Fujita Toshio, Winkler David A
Professor Emeritus at Kyoto University , 38-1 Iwakura-Miyakecho, Kyoto, Japan 606-0022.
CSIRO Manufacturing , Bag 10, Clayton South MDC 3169, Australia.
J Chem Inf Model. 2016 Feb 22;56(2):269-74. doi: 10.1021/acs.jcim.5b00229. Epub 2016 Jan 20.
Quantitative structure-activity relationship (QSAR) modeling has matured over the past 50 years and has been very useful in discovering and optimizing drug leads. Although its roots were in extra-thermodynamic relationships within small sets of chemically similar molecules focused on mechanistic interpretation, a second class of QSAR models has emerged that relies on machine learning methods to generate models from large, chemically diverse data sets for predictive purposes. There has been a tension between the two groups of QSAR practitioners that is unnecessary and possibly counterproductive. This paper explains the difference in philosophy and application of these two distinct, but equally important, classes of QSAR models and how they can work together synergistically to accelerate the discovery of new drugs or materials.
定量构效关系(QSAR)建模在过去50年中已经成熟,并且在发现和优化药物先导物方面非常有用。尽管它起源于专注于机理解释的一小类化学相似分子的超热力学关系,但现在已经出现了第二类QSAR模型,这类模型依靠机器学习方法从大量化学性质多样的数据集中生成模型用于预测目的。两组QSAR从业者之间存在一种紧张关系,这种紧张关系是不必要的,而且可能适得其反。本文解释了这两类截然不同但同样重要的QSAR模型在理念和应用上的差异,以及它们如何协同工作以加速新药或新材料的发现。